Product Program year 2023 Source: CMS Open Payments

iS3-iStent infiniteTrabecular Micro-Bypass System Model iS3

Device Glaucoma

Open in the dashboard

General payments

$41,405

553 payments

Research payments

$0

0 payments

Through program year 2023, $41,405 in general payments and $0 in research payments were reported against iS3-iStent infiniteTrabecular Micro-Bypass System Model iS3 (Glaucoma).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2023 General $41,405 553

Breakdown

Who paid General payments · program year 2023
  1. Glaukos Corporation $41,405 553 payments
Top recipients General payments · program year 2023
  1. Afshin Khodabakhsh Ophthalmology · Beverly Hills, CA $532 1% · 3 payments
  2. Jillian Chong Cornea and External Diseases Specialist · Beverly Hills, CA $490 1% · 3 payments
  3. David Hamilton Ophthalmology · Los Angeles, CA $490 1% · 3 payments
  4. Alison Granier Ophthalmology · Coeur D Alene, ID $358 <1% · 4 payments
  5. Nicole Fuerst Ophthalmology · West Covina, CA $327 <1% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Ophthalmology $30,556 74% · 331 practitioners
  2. Optometrist $5,971 14% · 77 practitioners
  3. Glaucoma Specialist Ophthalmology $2,755 7% · 26 practitioners
  4. Cornea and External Diseases Specialist Ophthalmology $808 2% · 5 practitioners
  5. Retina Specialist Ophthalmology $379 <1% · 2 practitioners

The top 5 of 15 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2023
  1. California $9,250 22% · 77 recipients
  2. New Jersey $4,076 10% · 28 recipients
  3. Indiana $3,020 7% · 27 recipients
  4. Pennsylvania $2,960 7% · 22 recipients
  5. Missouri $2,886 7% · 23 recipients

The top 5 of 44 states; each share is of general payments naming this product in 2023 where a state was reported.

The top 25 states, free in the app

553 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record